Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Mako-MORE Registry: Real-world Outcomes After Knee and Hip Arthroplasty

Official title: A Prospective, Multi-center, Post-market, Registry-based Evaluation of the Clinical Outcomes in Patients Receiving a Stryker Implant With Use of the Mako Robotic-Arm Assisted System (Mako-MORE)

Run by Stryker Orthopaedics · NCT07647354 · Data updated 2026-11-12

This registry collects real-world data from adults having hip or knee joint replacement with or without the Mako robotic system to see how they do over up to five years.

More Hip Arthropathy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment950 (estimated)
SponsorStryker Orthopaedics
Industry-sponsored
Locations5 sites (Jacksonville, Florida and 4 other locations)
StatusRecruiting
StartedJuly 13, 2026
Main results expectedMay 15, 2033
Study endsMarch 15, 2037
Registry record updatedAugust 18, 2026
Trial IDNCT07647354 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for manual or Mako robotic-arm assisted hip or knee arthroplasty who can consent and comply with follow-up visits.

Probably not a fit

Patients unable to provide informed consent or complete follow-up, or those not undergoing the specified arthroplasty procedures, may not experience study-related benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Mako-MORE Registry is a prospective, post-market study across multiple centers that tracks patients undergoing hip or knee arthroplasty with Stryker implants, using either Mako Robotic-Arm Assisted or manual techniques. It collects demographics, surgical details, patient-reported outcomes, health utility, radiographs, and adverse events. Patients are followed from before surgery through five years after the procedure to describe real-world safety and outcomes. Neither the devices nor the procedures are experimental; all practices align with FDA-cleared labeling and standard care. The study includes both Mako-assisted and manual cohorts to compare real-world performance and safety.

Why it matters

Potential benefit: If successful, the registry could clarify real-world safety and effectiveness of Mako-assisted arthroplasty and inform clinicians and patients about outcomes in routine care.

How similar studies have gone: Prior registry efforts have demonstrated the value of real-world data in orthopedic implants, with mixed but informative results guiding practice.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The subject is skeletally mature, and ≥ 18 years old.
* The Subject has signed and dated an IRB/EC approved, study specific Informed Patient Consent Form (ICF).
* The subject is scheduled to undergo manual arthroplasty or Mako Robotic-Arm Assisted Arthroplasty according to IFU.
* The subject is willing and able to comply with postoperative scheduled clinical evaluations.

Exclusion Criteria:

* The subject is not able to express his/her consent as deemed by the investigator.
* The subject is not able to fulfill a self-assessment questionnaire or follow-up visits as deemed by the investigator.
* The subject is a prisoner.
* Per surgeon discretion the subject is not a candidate for the study.
* The subject is pregnant or breastfeeding.

Where it's running

  • UofL Health
    Louisville, Kentucky, United States
    Recruiting
  • NYU Langone Orthopedic Hospital
    New York, New York, United States
    Recruiting
  • Mayo Clinic (Jacksonville)
    Jacksonville, Florida, United States
    Not yet recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Not yet recruiting
  • Robotic Joint Replacement Institute - Ortho Rhode Island
    Wakefield, Rhode Island, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.